基于两步算法的艰难梭菌检测作为抗菌药物管理工具
该回顾性分析纳入2年间610例艰难梭菌阳性病例,比较PCR检测期与两步法检测期(结果分别显示为「可能定植」或「毒素阳性」)的CDI特异性治疗率及不良结局。PCR组93%(329/354)接受治疗,可能定植组42%(59/142)接受治疗,毒素阳性组全部(114/114)接受治疗;多因素分析显示两步法检测期送检与接受CDI治疗的可能性更低(OR 0.05,95% CI 0.03-0.09)。
要点
- PCR组93%(329/354)接受CDI特异性治疗,可能定植组42%(59/142)接受治疗,毒素阳性组114例全部接受治疗。
- PCR阳性或可能定植患者的多因素分析显示,两步法检测期送检与CDI治疗可能性降低相关(OR 0.05,95% CI 0.03-0.09)。
- 改变检测方法及结果呈现方式与CDI特异性抗生素使用减少相关,且未限制临床医生开立诊断检测。
核心结论
- 改变检测方法及结果呈现方式与CDI特异性抗生素使用减少相关,且未限制临床医生开立诊断检测。
研究设计与样本
- 对2年间艰难梭菌阳性病例进行回顾性分析,涵盖本机构从PCR过渡到两步法检测之前一年和之后一年。
- PCR检测期结果在电子病历中显示为「阳性」;两步法检测期阳性结果分别显示为「可能定植」或「毒素阳性」。
- 比较三组CDI特异性治疗率及不良患者结局(30天死亡率和重症监护室入住)。
主要发现
- 研究期间共610例患者结果阳性;PCR组354例中329例(93%)接受CDI特异性治疗。
- 可能定植组142例中59例(42%)接受治疗;毒素阳性组114例全部接受治疗。
- 对PCR阳性或可能定植患者的多因素分析显示,两步法检测期送检与CDI治疗可能性降低相关(OR 0.05,95% CI 0.03-0.09)。
关键数值与推荐
- PCR阳性或可能定植患者中,两步法检测期送检与治疗的OR为0.05(95% CI 0.03-0.09)。
临床怎么用
- 原文结论指出改变检测类型及结果呈现方式与CDI特异性抗生素使用减少相关,且未限制临床医生开立诊断检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Diagnosis of Clostridium difficile infection (CDI) can be challenging due to high colonization rates. Unlike PCR-only testing, two-step algorithm testing (that includes toxin and PCR) may help differentiate colonization from active infection, but it is unknown if this type of testing impacts treatment decisions. We examined the association between changing CDI diagnostic methods, the way the testing results were displayed, and the rates of CDI-specific treatment. METHODS: We performed a retrospective analysis of positive C. difficile cases over 2 years, a year preceding and following our institution's transition from PCR to two-step testing. During the PCR period, results were displayed in the electronic medical record as 'positive'. In the two-step period, positive results were either displayed as 'likely colonized' or 'toxin positive'. Rates of CDI-specific therapy and adverse patient outcomes (30-day mortality and intensive care unit admission) were compared among the three groups. RESULTS: A total of 610 patients had positive results over the study period. Of the 354 patients in the PCR group, 329 (93%) were treated with CDI-specific therapy. Of the 142 patients in the likely colonized group, 59 (42%) were treated. All 114 patients in the toxin-positive group were treated. Multivariate analysis of patients who were PCR positive or likely colonized showed that tests sent in the two-step era were less likely to be associated with treatment for CDI (odds ratio 0.05, 95% CI 0.03-0.09). DISCUSSION: We found a correlation between changing the type of test and the way the results were displayed and reduction in CDI-specific antibiotic use without restricting clinician diagnostic ordering.
引用
- Dbeibo L, Lucky CW, Fadel WF, et al. Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship. Clin Microbiol Infect. 2023. PMID: 36804907. doi:10.1016/j.cmi.2023.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。